Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants

The recent pandemic of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has raised global health concerns. The viral 3-chymotrypsin-like cysteine protease (3CL(pro)) enzyme controls coronavirus replication and is essential for its life cycle. 3CL(pro) is a proven drug discovery target in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tahir ul Qamar, Muhammad, Alqahtani, Safar M., Alamri, Mubarak A., Chen, Ling-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Xi'an Jiaotong University 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156227/
https://www.ncbi.nlm.nih.gov/pubmed/32296570
http://dx.doi.org/10.1016/j.jpha.2020.03.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156227/
https://www.ncbi.nlm.nih.gov/pubmed/32296570
http://dx.doi.org/10.1016/j.jpha.2020.03.009

Ejemplares similares